Skip to main content
TSHA logo

TSHA · Taysha Gene Therapies, Inc. · Documents

Track TSHA — free
$3.99 -0.01 (-0.25%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.30B
Shares
326.05M
Volume · Nov 18 3.55M Avg daily vol (3M) 3.62M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023
Mar 28
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $2.5M Net loss $166.01M Diluted EPS -$3.78
2022
2021
Showing 101–150 of 171 documents
Key facts CIK 1806310 CUSIP 877619106 13F (30d) 217 filings 199 filers Visit website Investor relations